Press Room

Press Releases

June 24, 2008
NCPD Executive Committee Members Conduct Meetings in Sacramento on
Efforts to Reform Pedigree Law

The National Coalition of Pharmaceutical Distributors (NCPD) Position on SB1307

April 30, 2008
NCPD Release HR5839

May 30, 2007
Growing share of 'Big Three' gets federal attention Giant wholesalers dominate market, to hit quarter-trillion mark in sales
They are known as the "Big Three" in the pharmaceutical wholesale industry, and their control over the market is drawing the attention of lawmakers, the scrutiny of regulators and the wrath of smaller rivals who say they've had enough. ...

January 10, 2007
NCPD Seeks New Rules on Pharmaceutical Safety and Authentication
Imposition of a federal injunction on FDA highlights weaknesses in current regulatory policies...

In the Press

FDA Prescription Drug Marketing Act Questions and Answers
Guidance for Industry. This guidance represents the Food and Drug Administration’s (FDA’s) current thinking on this topic. ...

At deadline, pedigree law still plagued by questions
The long-delayed drug pedigree regulations announced by the Food & Drug Administration in mid-November have evoked a storm of criticism and lawsuits. No one is objecting to the FDA's stated goal of reducing drug diversion and counterfeits, but the cure may be worse than the disease...

Injunction - Objections - Decision and Order Round 2

RxUSA Final DOCKET# 06 CV 5086

NCPD Letter to Senator Snowe - Reimportation

HDMA AMICUS

RxUSA FDA Appeal Opening Brief

Pedigree Programs are Settling In
Ahead of about-to-be-announced FDA rules, state programs are changing the distribution marketplace...

Pedigree issue dogs distributors
Drug wholesalers, particularly small, independent companies, are sweating out the days until Dec. 1...

FDA to Enforce Drug Pedigree Rule
Two decades after Congress passed legislation to help stop counterfeit, adulterated, misbranded, and expired drugs from entering the U.S. supply chain, drug regulators on December 1 will fully implement the Prescription Drug Marketing Act (PDMA) of 1987, officials announced today...

Federal Drug-Tracking Program Flawed, Expert Says
The FDA’s plan to fight counterfeiting by tracking drugs through a pedigree system is not likely to accomplish the agency’s goals because of flaws in the federal statute, an expert says...

For additional information, contact karen.ciely@ncpdusa.org or info@ncpdusa.org